share_log

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $18

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $18

摩根士丹利維持對PetMed Express的減持,將目標股價下調至18美元
Benzinga Real-time News ·  2022/11/08 09:22

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $19 to $18.

摩根士丹利分析師艾琳·賴特維持PetMed Express(納斯達克股票代碼:PETS)持有減持,並將目標股價從19美元下調至18美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論